Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noninvasive Imaging During PDT for Actinic Keratoses
NCT05923060Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Aug 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in actinic keratosis (AK), sponsored by Case Comprehensive Cancer Center. Primary endpoints: Lesion Clearance at 3 months, Noninvasive optical measurements of photosensitizer (PpIX) in lesions at 3 months and 1 more. Started Aug 2024; status: completed.
02
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT05923060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923060.